Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

Europe - EPA:ALSOG - FR0000065864 - Common Stock

25.5 EUR
-0.4 (-1.54%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

6

ALSOG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 46 industry peers in the Aerospace & Defense industry. ALSOG has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALSOG. These ratings could make ALSOG a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ALSOG had positive earnings in the past year.
In the past year ALSOG had a positive cash flow from operations.
ALSOG had positive earnings in 4 of the past 5 years.
ALSOG had a positive operating cash flow in each of the past 5 years.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALSOG's Return On Assets of 3.53% is in line compared to the rest of the industry. ALSOG outperforms 45.65% of its industry peers.
With a Return On Equity value of 11.10%, ALSOG perfoms like the industry average, outperforming 45.65% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 9.75%, ALSOG is in the better half of the industry, outperforming 63.04% of the companies in the same industry.
ALSOG had an Average Return On Invested Capital over the past 3 years of 6.22%. This is below the industry average of 9.55%.
The last Return On Invested Capital (9.75%) for ALSOG is above the 3 year average (6.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.53%
ROE 11.1%
ROIC 9.75%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

ALSOG's Profit Margin of 3.17% is on the low side compared to the rest of the industry. ALSOG is outperformed by 63.04% of its industry peers.
In the last couple of years the Profit Margin of ALSOG has grown nicely.
ALSOG has a Operating Margin of 5.80%. This is in the lower half of the industry: ALSOG underperforms 71.74% of its industry peers.
ALSOG's Operating Margin has improved in the last couple of years.
ALSOG's Gross Margin of 59.16% is amongst the best of the industry. ALSOG outperforms 86.96% of its industry peers.
In the last couple of years the Gross Margin of ALSOG has remained more or less at the same level.
Industry RankSector Rank
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALSOG is creating some value.
ALSOG has about the same amout of shares outstanding than it did 1 year ago.
ALSOG has a better debt/assets ratio than last year.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.51 indicates that ALSOG is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALSOG has a worse Altman-Z score (2.51) than 60.87% of its industry peers.
The Debt to FCF ratio of ALSOG is 1.39, which is an excellent value as it means it would take ALSOG, only 1.39 years of fcf income to pay off all of its debts.
ALSOG has a Debt to FCF ratio of 1.39. This is amongst the best in the industry. ALSOG outperforms 86.96% of its industry peers.
ALSOG has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.44, ALSOG is doing good in the industry, outperforming 63.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Altman-Z 2.51
ROIC/WACC1.25
WACC7.8%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.66 indicates that ALSOG should not have too much problems paying its short term obligations.
ALSOG has a better Current ratio (1.66) than 78.26% of its industry peers.
A Quick Ratio of 1.41 indicates that ALSOG should not have too much problems paying its short term obligations.
ALSOG has a Quick ratio of 1.41. This is amongst the best in the industry. ALSOG outperforms 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.41
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

ALSOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.16%, which is quite impressive.
The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
Looking at the last year, ALSOG shows a small growth in Revenue. The Revenue has grown by 2.53% in the last year.
Measured over the past years, ALSOG shows a quite strong growth in Revenue. The Revenue has been growing by 9.06% on average per year.
EPS 1Y (TTM)76.16%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%

3.2 Future

ALSOG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.42% yearly.
Based on estimates for the next years, ALSOG will show a small growth in Revenue. The Revenue will grow by 6.01% on average per year.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.45, ALSOG is valued correctly.
Based on the Price/Earnings ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
ALSOG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.83.
Based on the Price/Forward Earnings ratio of 9.82, the valuation of ALSOG can be described as reasonable.
Based on the Price/Forward Earnings ratio, ALSOG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ALSOG is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.45
Fwd PE 9.82
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

97.83% of the companies in the same industry are more expensive than ALSOG, based on the Enterprise Value to EBITDA ratio.
ALSOG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALSOG is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.07
EV/EBITDA 7.44
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ALSOG may justify a higher PE ratio.
ALSOG's earnings are expected to grow with 18.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.71%, ALSOG has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.09, ALSOG pays a better dividend. On top of this ALSOG pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, ALSOG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.71%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

58.45% of the earnings are spent on dividend by ALSOG. This is a bit on the high side, but may be sustainable.
DP58.45%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (11/7/2025, 7:00:00 PM)

25.5

-0.4 (-1.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-29 2025-10-29
Earnings (Next)01-27 2026-01-27
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap81.60M
Revenue(TTM)158.49M
Net Income(TTM)5.03M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.71%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP58.45%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.45
Fwd PE 9.82
P/S 0.51
P/FCF 4.07
P/OCF 3.82
P/B 1.8
P/tB 3.32
EV/EBITDA 7.44
EPS(TTM)1.65
EY6.47%
EPS(NY)2.6
Fwd EY10.18%
FCF(TTM)6.27
FCFY24.59%
OCF(TTM)6.68
OCFY26.18%
SpS49.53
BVpS14.16
TBVpS7.68
PEG (NY)0.58
PEG (5Y)N/A
Graham Number22.93
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 11.1%
ROCE 11.29%
ROIC 9.75%
ROICexc 12.06%
ROICexgc 17.44%
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
FCFM 12.66%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexgc growth 3Y2.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Debt/EBITDA 1.61
Cap/Depr 38.54%
Cap/Sales 0.82%
Interest Coverage 9.7
Cash Conversion 170.17%
Profit Quality 398.97%
Current Ratio 1.66
Quick Ratio 1.41
Altman-Z 2.51
F-Score8
WACC7.8%
ROIC/WACC1.25
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.16%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y48.74%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y978.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y779.78%
OCF growth 3Y101.39%
OCF growth 5YN/A

SOGECLAIR / ALSOG.PA FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


What is the valuation status for ALSOG stock?

ChartMill assigns a valuation rating of 8 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Undervalued.


What is the profitability of ALSOG stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for ALSOG stock?

The financial health rating of SOGECLAIR (ALSOG.PA) is 6 / 10.


What is the earnings growth outlook for SOGECLAIR?

The Earnings per Share (EPS) of SOGECLAIR (ALSOG.PA) is expected to grow by 26.7% in the next year.